Trial Profile
Prospective, open, multicentre clinical trial (phase II) of Endostar(recombinant human endostatin) on combined radiotherapy and chemotherapy for esophageal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Endostatin (Primary) ; Paclitaxel (Primary)
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Jan 2012 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
- 15 Mar 2011 New trial record